Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say
Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical ...
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
Bain Capital is in talks to acquire Mitsubishi Chemical Group’s pharmaceutical business in a potential multibillion-dollar ...
Bain Capital Reportedly In Talks To Buy Mitsubishi Chemical's Pharma Unit For $3.2 Bln
Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma Corp., affiliated to Japan's Mitsubishi Chemical Group ...
Wall Street Journal6d
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
The U.S. investment company is in the final stages of negotiations to buy the subsidiary, Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person ...
MarketWatch6d
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said. The U.S. investment company ...
Health Care Up on GLP-1 Alzheimer's Data -- Health Care Roundup
Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs, rallied ...
PRESS DIGEST- Wall Street Journal - Jan 21
The following are the top stories in the Wall Street Journal. - Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, ...